Published in Bull Exp Biol Med on October 01, 2003
Modeling of presymptomatic and symptomatic stages of parkinsonism in mice. Neuroscience (2011) 1.39
[Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect]. Biull Eksp Biol Med (1999) 0.90
[Similarity of cycloprolylglycine to piracetam in antihypoxic and neuroprotective effects]. Eksp Klin Farmakol (2012) 0.87
[Design and synthesis of dipeptide mimetics of brain-derived neurotrophic factor]. Bioorg Khim (2012) 0.86
Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin. Bull Exp Biol Med (2011) 0.81
Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model. Behav Pharmacol (1999) 0.80
[Identification in the rat brain of cyclo-prolylglycine, a novel endogenous peptide with nootropic activity]. Dokl Akad Nauk (1996) 0.80
Neuroprotective and antiamnestic effect of nerve growth factor dipeptide mimetic GK-2 in experimental ischemic infarction of brain cortex. Bull Exp Biol Med (2011) 0.79
In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic. Bull Exp Biol Med (2011) 0.79
[Antagonism of piracetam with proline in relation to mnestic effects]. Biull Eksp Biol Med (1985) 0.79
[The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]. Eksp Klin Farmakol (1996) 0.79
[Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization]. Eksp Klin Farmakol (1998) 0.78
Therapeutic efficacy of the neuroprotective plant adaptogen in neurodegenerative disease (Parkinson's disease as an example). Bull Exp Biol Med (2010) 0.78
[Strategy for the development of dipeptide drugs]. Vestn Ross Akad Med Nauk (2011) 0.78
[Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123]. Eksp Klin Farmakol (2002) 0.78
[The original novel nootropic and neuroprotective agent noopept]. Eksp Klin Farmakol (2003) 0.77
Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments. Bull Exp Biol Med (2011) 0.77
The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels. Gen Pharmacol (1997) 0.77
Liposomes containing dopamine entrapped in response to transmembrane ammonium sulfate gradient as carrier system for dopamine delivery into the brain of parkinsonian mice. J Liposome Res (2001) 0.77
[Preservation of plastic properties of synaptic transmission in long-lasting hippocampal slices under the effects of a peptide analog of piracetam, L-pGlu-D-Ala-NH2]. Biull Eksp Biol Med (1990) 0.77
Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Bull Exp Biol Med (2000) 0.76
Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer's Disease. Acta Naturae (2013) 0.76
Experimental modeling of preclinical and clinical stages of Parkinson's disease. Bull Exp Biol Med (2011) 0.76
[Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept]. Eksp Klin Farmakol (2008) 0.76
Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration. Bull Exp Biol Med (2000) 0.76
[Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine]. Eksp Klin Farmakol (2002) 0.76
[Neuroprotective effects of a dipeptide mimetic on the GK-2 nerve growth factor in model of permanent common carotid artery occlusion in rats]. Eksp Klin Farmakol (2012) 0.76
Endogenous dipeptide cycloprolylglycine shows selective anxiolytic activity in animals with manifest fear reaction. Bull Exp Biol Med (2002) 0.76
Nootropic compound L-pyroglutamyl-D-alanine-amide restores hippocampal long-term potentiation impaired by exposure to ethanol in rats. Neurosci Lett (1995) 0.75
[Antifibrillatory activity of dipeptide antagonist of nerve growth factor]. Fiziol Cheloveka (2012) 0.75
[Modulation of the long-term memory by delayed administration of the nootropic agent L-pyroglutamyl-D-alaninamide during spaced and massed training of rats]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
Noopept normalizes parameters of the incretin system in rats with experimental diabetes. Bull Exp Biol Med (2014) 0.75
[The correction with nooglutil and L-pyroglutamyl-D-alanine amide of cognitive disorders in rats due to intrauterine hypoxia]. Eksp Klin Farmakol (1996) 0.75
Antihypoxic activity of cycloprolylglycine analogs. Bull Exp Biol Med (2015) 0.75
Role of the cholecystokinin system in anxiolytic activity of dipeptide GB-115. Bull Exp Biol Med (2012) 0.75
[Behavioral and morphologic disorders caused by bilateral photoinduced thrombosis of the cerebral vessels of the frontal cortex in rats]. Patol Fiziol Eksp Ter (1998) 0.75
Immunopharmacological properties of noopept. Bull Exp Biol Med (2007) 0.75
[Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity]. Eksp Klin Farmakol (2009) 0.75
Neuroprotective effects of dipeptide analogue of brain-derived neurotrophic factor GSB-106 in in vitro experiments. Bull Exp Biol Med (2013) 0.75
[An experimental study of the anti-inflammatory action of noopept and its effect on the level of cytokines]. Eksp Klin Farmakol (2012) 0.75
[Damage to plastic properties of synaptic transmission in the rat hippocampus resulting from prenatal hypoxia, and their normalization by treatment with nootropic dipeptides]. Biull Eksp Biol Med (1995) 0.75
Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices. Bull Exp Biol Med (2004) 0.75
Immunocorrecting properties of GB-115 dipeptide. Bull Exp Biol Med (2008) 0.75
Modulation of long-term memory by delayed administration of the amide of L-pyroglutamyl-D-alanine, a nootropic agent, in spaced and massed training in rats. Neurosci Behav Physiol (1999) 0.75
Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration. Bull Exp Biol Med (2001) 0.75
[Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111)]. Eksp Klin Farmakol (2001) 0.75
[A comparative analysis of the effect of nootropic preparations with different chemical structures on the failure of the escape reaction in rats]. Eksp Klin Farmakol (1995) 0.75
[Hypocoagulant effect of the novel dipeptide NGF mimetic GK-2]. Eksp Klin Farmakol (2013) 0.75
Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115. Bull Exp Biol Med (2007) 0.75
Antidiabetic activity of a novel dipeptide mimetic of nerve growth factor. Dokl Biol Sci (2013) 0.75
[The study of biologically active conformation of cholecystokinin-4 dipeptide analog GB-115]. Bioorg Khim (2014) 0.75
[Investigation of multyphytoadaptogene anti-radiation activity in mice]. Patol Fiziol Eksp Ter (2013) 0.75
[Effect of dipeptide neurotensin analog dilept on extracellular concentrations of glutamate, GABA and HVA in N. accumbens of rat brain]. Eksp Klin Farmakol (2010) 0.75
[Synthesis of cyclic analogues of the nerve growth factor loop 4]. Bioorg Khim (2008) 0.75
[Studying in vitro neuroprotective properties of GK-2(h)--a new original mimetic of human nerve growth factor]. Eksp Klin Farmakol (2014) 0.75
[The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction]. Eksp Klin Farmakol (1998) 0.75
[The comparative characteristics of the effect of piracetam peptide analogs on the recovery of conditioned reflex activity in animals following damage to the frontal cortex and the electrophysiological characteristics of the brain integrative activity]. Eksp Klin Farmakol (1993) 0.75
The novel substituted acylproline-containing dipeptide, GVS-111, promotes the restoration of learning and memory impaired by bilateral frontal lobectomy in rats. Behav Pharmacol (1997) 0.75
[EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES]. Eksp Klin Farmakol (2015) 0.75
[Detection of nootropic activity indicated by acute inhibition of orientation reaction]. Biull Eksp Biol Med (1991) 0.75
[Neuroprotective and antiamnesic effects of GK-2h dipeptide HNGF mimetic on a model of experimental ischemic stroke of brain cortex prefrontal areas]. Eksp Klin Farmakol (2012) 0.75
Neuroprotective effect of dipeptide AVP(4-5)-NH2 is associated with nerve growth factor and heat shock protein HSP70. Bull Exp Biol Med (2007) 0.75
Effects of neurotensin dipeptide analog dilept on dopamine metabolism and synthesis in the nucleus accumbens of Wistar rats. Bull Exp Biol Med (2012) 0.75
[L-pyroglutamyl-D-alanine amide normalizes the function of the developing brain damaged by antenatal alcoholization in rats]. Biull Eksp Biol Med (1990) 0.75
Antiamnesic effect of acyl-prolyl-containing dipeptide (GVS-111) in compression-induced damage to frontal cortex. Bull Exp Biol Med (2000) 0.75
[Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome]. Eksp Klin Farmakol (2011) 0.75
"Provocation test" as a novel approach to early diagnosis of Parkinson's disease. Dokl Biol Sci (2015) 0.75
[Behavioral and electrophysiologic characteristics of a peptide analog of piracetam--L-pyroglutamyl-D-alanine amide]. Biull Eksp Biol Med (1987) 0.75
[PHARMACOLOGICAL STUDY OF NEW COMPOUNDS ACTING AS REGULATORS OF 18-KDA TRANSLOCATOR PROTEIN LIGANDS]. Eksp Klin Farmakol (2016) 0.75
[Design and synthesis of cholecystokinin-4 dipeptide analogues with anxiolytic and anxiogenic activities]. Bioorg Khim (2007) 0.75
[Interspecies differences of noopept pharmacokinetics]. Eksp Klin Farmakol (2004) 0.75
[Effect of the nootropic agents piracetam and GBS-111 on potential-dependent ion channels in the neuronal membrane]. Biull Eksp Biol Med (1996) 0.75
Regional and subcellular localization of cycloprolylglycine in rat brain. Bull Exp Biol Med (2010) 0.75
[Effects of noopept and cortexin on the behavior of matured rats treated with corticoliberin or 70-kDa heat shock proteins in early ontogeny]. Eksp Klin Farmakol (2007) 0.75
[Investigation of multyphytoadaptogene anti-radiation efficacy in dogs experiments]. Patol Fiziol Eksp Ter (2014) 0.75
[Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept]. Eksp Klin Farmakol (2009) 0.75
Effect of complex phytoadaptogen on MPTP-induced Parkinson's syndrome in mice. Bull Exp Biol Med (2006) 0.75
[The new tripeptoid neurotensin analog dilept selectively affects dopamine turnover in nucleus accumbens and hypothalamus]. Eksp Klin Farmakol (2006) 0.75
[The search of small molecules with antipsychotic activity on the background of neurotensin]. Bioorg Khim (2012) 0.75
[Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action]. Eksp Klin Farmakol (2005) 0.75
Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect. Bull Exp Biol Med (2005) 0.75
[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats]. Eksp Klin Farmakol (2013) 0.75
[The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites]. Eksp Klin Farmakol (1997) 0.75
Original nerve growth factor mimetic dipeptide GK-2 limits the manifestations of hemorrhagic stroke in rats. Bull Exp Biol Med (2013) 0.75
Anxiolytic activity of dipeptide GB-115 after oral administration. Bull Exp Biol Med (2013) 0.75
[Study of structure-activity relationship in series of Gsb-106 analogues-dipeptide mimetics of brain-derived neurotrophic factor]. Bioorg Khim (2015) 0.75
[Neuropharmacological properties of piracetam derivatives]. Biull Eksp Biol Med (1982) 0.75
Comparison of antipsychotic activity and discriminative stimulus effects of the novel acylprolyltyrosine containing compound, GZR-123, and sulpiride. Pharmacol Biochem Behav (1999) 0.75
[Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain]. Eksp Klin Farmakol (2002) 0.75
[Fibrin-depolymerization activity and the antiplatelet effect of small cyclic and linear proline-containing peptides]. Izv Akad Nauk Ser Biol (2005) 0.75
Study of anti-inflammatory effects of GB-115, a glycine-containing retropeptide cholecystokinin analog. Bull Exp Biol Med (2011) 0.75
Cyclopropyl glycine and proline-containing preparation noopept evoke two types of membrane potential responses in synaptoneurosomes. Bull Exp Biol Med (2003) 0.75
[Postresuscitation restoration of central nervous system functions during systemic administration of new peptide analog of pyracetam]. Biull Eksp Biol Med (1998) 0.75
[Effect of the nerve growth factor mimetic GK-2 on post-resuscitation expression of neurotrophic factors]. Patol Fiziol Eksp Ter (2015) 0.75
[Decrease in the glutamate release may contribute to the neuroprotective action of the novel neuroleptic drug dilept]. Eksp Klin Farmakol (2007) 0.75
Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bull Exp Biol Med (2008) 0.75
[The absence of tolerance and withdrawal syndrome after the treatment with the new L-tryptophane-containing dipeptide anxiolytic GB-115]. Vestn Ross Akad Med Nauk (2011) 0.75
Experimental study of antinociceptive potency of dipeptide GB-115 during chemical and thermal stimulation. Bull Exp Biol Med (2012) 0.75
[Mechanism of the antidepressive and learning-stimulating effects of thyroliberin and its analogs]. Biull Eksp Biol Med (1986) 0.75
[The efficacy of human NGF dipeptide mimetic on the streptozotocin-induced model of diabetes in rats]. Eksp Klin Farmakol (2013) 0.75